Irritable Bowel Drugs: Medications That Cause or Treat IBS

Match the Treatment to the IBS Pattern

IBS is a disorder of gut-brain interaction defined by recurrent abdominal pain associated with bowel changes. The first medication question is whether the current pattern is constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), mixed, or unsubtyped. The Bristol Stool Form Scale helps describe stool form, but it does not select a drug by itself (PMID 9299672).

The 2021 American College of Gastroenterology guideline grades diet, behavioral, and drug options and is the main evidence anchor for this overview (PMID 33315591). The related IBS differential guide explains why celiac disease, inflammatory bowel disease, microscopic colitis, bile-acid diarrhea, medication effects, and pelvic-floor disorders sometimes need to be considered first.

Medicines for IBS With Diarrhea

Rifaximin

Rifaximin is a minimally absorbed rifamycin antibacterial approved for adults with IBS-D. The exact Xifaxan label lists 550 mg three times daily for 14 days and permits up to two retreatment courses for recurrent symptoms. It can improve abdominal pain and stool consistency in some patients, but it is not indefinite daily antibiotic therapy.

Eluxadoline

Eluxadoline is a mixed opioid-receptor drug for adults with IBS-D. The Viberzi label contraindicates it in people without a gallbladder because of pancreatitis and sphincter-of-Oddi-spasm risk. It is also contraindicated with biliary obstruction, prior pancreatitis, severe liver impairment, severe or chronic constipation, mechanical obstruction, and alcohol abuse or more than three alcoholic drinks per day.

Alosetron

Alosetron is not a general first-line diarrhea drug. The Lotronex label restricts it to women with severe chronic IBS-D who have had anatomic or biochemical abnormalities excluded and have not responded adequately to conventional therapy. Serious constipation complications and ischemic colitis drive that narrow indication.

Loperamide and bile-acid binders

Loperamide can reduce stool frequency and urgency, but evidence is weaker for global IBS symptoms and abdominal pain. Bile-acid sequestrants may help selected patients with suspected bile-acid diarrhea, although response is not proof of IBS and tolerability varies. These options need to be fitted to the symptom target.

Medicines for IBS With Constipation

Linaclotide and plecanatide

Linaclotide and plecanatide are guanylate cyclase-C agonists that can improve constipation and abdominal symptoms. The current Linzess label lists 290 mcg once daily for adults with IBS-C. The Trulance label lists 3 mg once daily. Both labels contain important pediatric dehydration warnings; neither product should be treated as an ordinary laxative for children.

Lubiprostone

The Amitiza label approves 8 mcg twice daily for IBS-C in women age 18 and older. That sex-specific indication should not be silently generalized to every adult with constipation.

Tenapanor

Tenapanor inhibits the sodium/hydrogen exchanger 3. The Ibsrela label lists 50 mg twice daily immediately before breakfast or the first meal and immediately before dinner for adults with IBS-C. Severe diarrhea is a reason to suspend treatment and rehydrate.

Polyethylene glycol and soluble fiber

Polyethylene glycol can improve constipation frequency, but it may not improve global IBS pain. Soluble fiber such as psyllium can help some patients when started low and increased gradually; insoluble bran is more likely to aggravate bloating in susceptible people. These differences are why “take more fiber” is incomplete advice.

Pain, Bloating, and Gut-Brain Symptoms

The dominant complaint may be pain or bloating even when stool frequency is acceptable. Tricyclic antidepressants can reduce global IBS symptoms in selected patients and are often more compatible with diarrhea because constipation is a common adverse effect. Selective serotonin reuptake inhibitors are not interchangeable with tricyclics and may loosen stools in some people.

Antispasmodics and enteric-coated peppermint oil can help short-term abdominal pain for some patients, although product quality and adverse effects vary. Gut-directed psychotherapy is an evidence-based treatment for global IBS symptoms; its role reflects gut-brain biology, not a claim that symptoms are imaginary.

Drugs and Supplements That Can Mimic IBS

Medication effects can create diarrhea, constipation, gas, or pain that resembles IBS:

Do not abruptly stop a prescribed drug. Compare the symptom onset with start dates, dose changes, and formulation changes, then ask whether the medicine can be adjusted safely.

When to Reassess the Diagnosis

Age over 50 is not, by itself, proof that IBS is dangerous or that every person needs a colonoscopy. The more precise concern is new onset at an older age, being overdue for age-appropriate colorectal-cancer screening, or having alarm features. Current ACG colorectal-cancer guidance starts average-risk screening at 45 (ACG patient guidance).

Prompt evaluation is appropriate for rectal bleeding or black stool, iron-deficiency anemia, unintentional weight loss, fever, persistent vomiting, nocturnal symptoms, a palpable mass, family history of colorectal cancer or inflammatory bowel disease, or a major departure from the established pattern. Use the when-to-worry guide and next-steps guide to prepare for that review.